Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats

被引:29
|
作者
Wang, Jianping [1 ]
Zhang, Qing [1 ]
Mei, Xiuhua [1 ]
Zhang, Xiuzhen [1 ]
机构
[1] Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China
关键词
Anti-apoptosis; metalloproteinases; Hydroxysafflor Yellow A; left cardiac remodeling; left ventricular remodeling; MATRIX-METALLOPROTEINASE INHIBITION; ESSENTIAL-HYPERTENSION; DYSFUNCTION; APOPTOSIS; MORBIDITY; BCL-2; MASS;
D O I
10.3109/13880209.2013.805791
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Context: Hydroxysafflor yellow A (HSYA), the main chemical component of the safflower yellow pigments, is used extensively in traditional Chinese medicine for the treatment of cerebrovascular and cardiovascular diseases. Objective: The present study determined the effects of HSYA on left ventricular hypertrophy after pressure overload and investigated the underlying mechanisms. Materials and methods: Cardiac hypertrophy was induced by the ligation of abdominal aorta in male Wistar rats. The rats were then divided into five groups and treated with captopril (100 mg/kg) or HSYA at different doses (0, 10, 20 and 40 mg/kg). Six weeks after treatment, the weight of left ventricle, LVMI (left ventricular mass index) and pathological changes were measured. MMP-2 (metalloproteinase 2) and MMP-9 (metalloproteinase 9) levels were determined by ELISA. Protein expressions of Bcl-2 and Bax were evaluated by immunohistochemistry. Results: HSYA (20, 40 mg/kg) significantly attenuated the increase of LVMI (ventricular weight/body weight) by 13.04 and 30.43% respectively, when compared with the model group. This was associated with the amelioration of pathological lesion, such as cardiac muscle fibers were smaller and the nuclei of cardiomyocytes were lightly stained in animals treated with HSYA (20, 40 mg/kg). In addition, the administration of HSYA at doses of 20 and 40 mg/kg increased the Bcl-2/Bax ratio (1.17 +/- 0.08 and 1.39 +/- 0.07 versus 0.71 +/- 0.06). In addition, the serum MMP-2 and MMP-9 levels were blocked by the treatment at doses of 20 and 40 mg/kg HSYA (MMP-2, 76.1 +/- 9.2 and 65.6 +/- 6.8 versus 82.9 +/- 6.2, ng/ml; MMP-9, 66.6 +/- 4.8 and 57.5 +/- 5.0 versus 83.5 +/- 6.0, ng/ml). Conclusion: These findings indicated that HSYA has beneficial effects on hypertensive ventricular remodeling, which may involve mechanisms of inhibiting cell apoptosis and suppressing metalloproteinases expression.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [31] Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation
    Yong-nan Fu
    Han Xiao
    Xiao-wei Ma
    Sheng-yang Jiang
    Ming Xu
    You-yi Zhang
    Acta Pharmacologica Sinica, 2011, 32 : 879 - 887
  • [32] Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy
    van de Schans, Veerle A. M.
    van den Borne, Susanne W. M.
    Strzelecka, Agnieszka E.
    Janssen, Ben J. A.
    van der Velden, Jos L. J.
    Langen, Ramon C. J.
    Wynshaw-Boris, Antony
    Smits, Jos F. M.
    Blankesteijn, W. Matthijs
    HYPERTENSION, 2007, 49 (03) : 473 - 480
  • [33] Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation
    Fu, Yong-nan
    Xiao, Han
    Ma, Xiao-wei
    Jiang, Sheng-yang
    Xu, Ming
    Zhang, You-yi
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (07) : 879 - 887
  • [34] MKP-5 Deficiency Attenuates Pressure Overload-induced Cardiac Hypertrophy
    Min, Kisuk
    Huang, Yan
    Giordano, Frank J.
    Bajpeyi, Sudip
    Bennett, Anton M.
    CIRCULATION, 2020, 142
  • [35] Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species
    Liu, Jinjun
    Zhou, Juan
    An, Wenjiao
    Lin, Yuanxi
    Yang, Yubai
    Zang, Weijin
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 88 (07) : 745 - 752
  • [36] Vitamin D attenuates pressure overload-induced cardiac remodeling and dysfunction in mice
    Zhang, Liang
    Yan, Xiao
    Zhang, Yun-Long
    Bai, Jie
    Hidru, Tesfaldet Habtemariam
    Wang, Qing-Shan
    Li, Hui-Hua
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 178 : 293 - 302
  • [37] Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis
    Sari, Nurmila
    Katanasaka, Yasufumi
    Sugiyama, Yuga
    Sunagawa, Yoichi
    Miyazaki, Yusuke
    Funamoto, Masafumi
    Shimizu, Satoshi
    Shimizu, Kana
    Murakami, Akira
    Mori, Kiyoshi
    Wada, Hiromichi
    Hasegawa, Koji
    Morimoto, Tatsuya
    PHYTOMEDICINE, 2021, 92
  • [38] The role of gender in the regression of pressure overload-induced left ventricular myocardial hypertrophy
    Ruppert, M.
    Korkmaz-Icoz, S.
    Loganathan, S.
    Jiang, W.
    Lehmann, L.
    Olah, A.
    Barta, B. A.
    Merkely, B.
    Karck, M.
    Szabo, G.
    Radovits, T.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 120 : 13 - 13
  • [39] Electrophysiologic Remodeling of the Left Ventricle in Pressure Overload-Induced Right Ventricular Failure
    Hardziyenka, Maxim
    Campian, Maria E.
    Verkerk, Arie O.
    Surie, Sulaiman
    van Ginneken, Antoni C. G.
    Hakim, Sara
    Linnenbank, Andre C.
    de Bruin-Bon, H. A. C. M. Rianne
    Beekman, Leander
    van der Plas, Mart N.
    Remme, Carol A.
    van Veen, Toon A. B.
    Bresser, Paul
    de Bakker, Jacques M. T.
    Tan, Hanno L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (24) : 2193 - 2202
  • [40] CELLULAR BASIS OF WALL REMODELING IN LONG-TERM PRESSURE OVERLOAD-INDUCED RIGHT VENTRICULAR HYPERTROPHY IN RATS
    OLIVETTI, G
    RICCI, R
    LAGRASTA, C
    MANIGA, E
    SONNENBLICK, EH
    ANVERSA, P
    CIRCULATION RESEARCH, 1988, 63 (03) : 648 - 657